title: WT1 peptide vaccination following allogeneic stem cell transplantation in pediatric leukemic patients with high risk for relapse: successful maintenance of durable remission.
authors.forename: Y
authors.initials: Y
authors.lastname: Hashii
authors.forename: E
authors.initials: E
authors.lastname: Sato-Miyashita
authors.forename: R
authors.initials: R
authors.lastname: Matsumura
authors.forename: S
authors.initials: S
authors.lastname: Kusuki
authors.forename: H
authors.initials: H
authors.lastname: Yoshida
authors.forename: H
authors.initials: H
authors.lastname: Ohta
authors.forename: N
authors.initials: N
authors.lastname: Hosen
authors.forename: A
authors.initials: A
authors.lastname: Tsuboi
authors.forename: Y
authors.initials: Y
authors.lastname: Oji
authors.forename: Y
authors.initials: Y
authors.lastname: Oka
authors.forename: H
authors.initials: H
authors.lastname: Sugiyama
authors.forename: K
authors.initials: K
authors.lastname: Ozono
mesh_terms: D000293:Adolescent; D019496:Cancer Vaccines / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D005260:Female; D006086:Graft vs Host Disease / Q000209:etiology; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects; D006801:Humans; D007223:Infant; D007938:Leukemia / Q000235:genetics / Q000276:immunology / Q000628:therapy*; D008297:Male; D010455:Peptides / Q000737:chemistry / Q000276:immunology; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D012008:Recurrence; D012306:Risk; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D014184:Transplantation, Homologous; D025721:WT1 Proteins / Q000737:chemistry* / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*
chemical_list: D019496:Cancer Vaccines; D010455:Peptides; D012333:RNA, Messenger; D025721:WT1 Proteins